190 related articles for article (PubMed ID: 34583200)
21. Association of urine and plasma ADMA with atherosclerotic risk in DKD cardiovascular disease risk in diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
Schrauben SJ; Sapa H; Xie D; Zhang X; Anderson AH; Shlipak MG; Hsu CY; Shafi T; Mehta R; Bhat Z; Brown J; Charleston J; Chen J; He J; Ix JH; Rao P; Townsend R; Kimmel PL; Vasan RS; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
Nephrol Dial Transplant; 2023 Nov; 38(12):2809-2815. PubMed ID: 37230949
[TBL] [Abstract][Full Text] [Related]
22. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
[TBL] [Abstract][Full Text] [Related]
23. Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method.
Tang Y; Zou Y; Cui J; Ma X; Zhang L; Yu S; Qiu L
Clin Chim Acta; 2022 Nov; 536():162-168. PubMed ID: 36191613
[TBL] [Abstract][Full Text] [Related]
24. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
[TBL] [Abstract][Full Text] [Related]
25. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
27. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
28. Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography.
Liu X; Xie Z; Sun M; Wang X; Li J; Cui J; Zhang F; Yin L; Huang D; Hou J; Tian J; Yu B
Int J Cardiol; 2018 Aug; 265():18-23. PubMed ID: 29729869
[TBL] [Abstract][Full Text] [Related]
29. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
Skagen K; Trøseid M; Ueland T; Holm S; Abbas A; Gregersen I; Kummen M; Bjerkeli V; Reier-Nilsen F; Russell D; Svardal A; Karlsen TH; Aukrust P; Berge RK; Hov JE; Halvorsen B; Skjelland M
Atherosclerosis; 2016 Apr; 247():64-9. PubMed ID: 26868510
[TBL] [Abstract][Full Text] [Related]
30. Diabetes is Associated with Higher Trimethylamine N-oxide Plasma Levels.
Dambrova M; Latkovskis G; Kuka J; Strele I; Konrade I; Grinberga S; Hartmane D; Pugovics O; Erglis A; Liepinsh E
Exp Clin Endocrinol Diabetes; 2016 Apr; 124(4):251-6. PubMed ID: 27123785
[TBL] [Abstract][Full Text] [Related]
31. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
32. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
33. Microbiota-Dependent Marker TMAO Is Elevated in Silent Ischemia but Is Not Associated With First-Time Myocardial Infarction in HIV Infection.
Haissman JM; Knudsen A; Hoel H; Kjær A; Kristoffersen US; Berge RK; Katzenstein TL; Svardal A; Ueland T; Aukrust P; Lebech AM; Nielsen SD; Trøseid M
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):130-6. PubMed ID: 26413854
[TBL] [Abstract][Full Text] [Related]
34. Plasma Trimethylamine-
Lemaitre RN; Jensen PN; Wang Z; Fretts AM; Sitlani CM; Nemet I; Sotoodehnia N; de Oliveira Otto MC; Zhu W; Budoff M; Longstreth WT; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2023 Aug; 12(16):e8711. PubMed ID: 37581385
[TBL] [Abstract][Full Text] [Related]
35. Assessment of trimethylamine N-oxide (TMAO) as a potential biomarker of severe stress in patients vulnerable to posttraumatic stress disorder (PTSD) after acute myocardial infarction.
Baranyi A; Enko D; von Lewinski D; Rothenhäusler HB; Amouzadeh-Ghadikolai O; Harpf H; Harpf L; Traninger H; Obermayer-Pietsch B; Schweinzer M; Braun CK; Meinitzer A
Eur J Psychotraumatol; 2021 May; 12(1):1920201. PubMed ID: 34104352
[No Abstract] [Full Text] [Related]
36. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
37. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Tang WH; Wang Z; Levison BS; Koeth RA; Britt EB; Fu X; Wu Y; Hazen SL
N Engl J Med; 2013 Apr; 368(17):1575-84. PubMed ID: 23614584
[TBL] [Abstract][Full Text] [Related]
38. Serum Trimethylamine N-Oxide Levels Correlate with Metabolic Syndrome in Coronary Artery Disease Patients.
Kuo CH; Liu CH; Wang JH; Hsu BG
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886563
[TBL] [Abstract][Full Text] [Related]
39. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
[No Abstract] [Full Text] [Related]
40. Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease.
Thomas MS; Fernandez ML
Curr Atheroscler Rep; 2021 Feb; 23(4):12. PubMed ID: 33594574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
